Page last updated: 2024-10-29

ifosfamide and Inflammatory Bowel Diseases

ifosfamide has been researched along with Inflammatory Bowel Diseases in 1 studies

Inflammatory Bowel Diseases: Chronic, non-specific inflammation of the GASTROINTESTINAL TRACT. Etiology may be genetic or environmental. This term includes CROHN DISEASE and ULCERATIVE COLITIS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dunsmore, G1
Koleva, P1
Ghobakhloo, N1
Sutton, R1
Ambrosio, L1
Meng, X1
Hotte, N1
Nguyen, V1
Madsen, KL1
Dieleman, LA1
Huang, V1
Elahi, S1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Diagnostic Value and Biological Significant of cd71 in Lymphoid Dis Order[NCT03720977]139 participants (Anticipated)Observational2019-12-01Not yet recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for ifosfamide and Inflammatory Bowel Diseases

ArticleYear
Lower Abundance and Impaired Function of CD71+ Erythroid Cells in Inflammatory Bowel Disease Patients During Pregnancy.
    Journal of Crohn's & colitis, 2019, Feb-01, Volume: 13, Issue:2

    Topics: Animals; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease Models, An

2019